“Stopping Alzheimer’s before it starts” - This is the slogan of a this nationwide, collaborative project in the Netherlands, led by Wiesje van der Flier from Alzheimer Center Amsterdam. ABOARD...
Current work
Alzheimer Europe contributes to a number of European research projects on dementia, funded through Horizon 2020, the Innovative Health Initiative (IHI), the EU Joint Programme – Neurodegenerative Disease Research (JPND) and other programmes. In these projects, Alzheimer Europe provides the views of people with dementia, their carers, and those of national Alzheimer's associations; contributes to the discussion of ethical issues in research; and supports the communication of project activities to the wider dementia community and the general public.
In this section, you can find information about these research projects and our contributions to their work.
Recent advances in disease-modifying therapies and the huge potential benefits of preventive multidomain interventions based on modifiable lifestyle and vascular factors provide new opportunities for early detection, prevention and treatment...
ADIS stands for "Early Diagnosis of Alzheimer's Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances." The project is funded by the EU Joint Programme for Neurodegenerative...
AI-Mind is a 5-year, EU-funded Horizon 2020 project that brings together 15 partners from 8 countries, including academic institutions, medical centers, SMEs and patient associations. Starting in March 2021, AI-Mind...
Dementia is a leading cause of disability and can have significant impact on quality of life. In addition to progressive cognitive decline, people with dementia frequently experience non-cognitive (e.g. behavioural...
The eBRAIN-Health project is developing a secure research platform for “digital twins” of the brain. Using these digital versions of individuals to model disease progression could accelerate brain research, and...
The European Platform for Neurodegenerative Diseases (EPND) integrates existing initiatives to build, grow, and deliver a scalable and self-sustainable platform for storage and analysis of high-quality clinical samples and data...
LETHE (A personalised prediction and intervention model for early detection and reduction of risk factors causing dementia, based on AI and distributed Machine Learning) is a four-year project. LETHE aims...
Multi-MeMo stands for “Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia”. Funded by JPND, the project aligns experimental molecular, cellular, and animal models with a very strong array...
Pattern-Cog stands for “Personalised ageing pattern for early risk detection and prevention of cognitive impairment and dementia in cognitively healthy individuals”. Funded by ERA PerMed, the project aims to improve...
PREDICTOM is an international cross-sector collaborative effort. It includes partners working in academia, business and hospitals in Europe, Asia and America from 15 different countries, as well as over 4,000...
Aberrant insulin signalling has a substantial impact on health and socioeconomic factors through its role in diabetes, metabolic syndrome, and obesity. Altered insulin signalling also appears to be implicated in...
PROMINENT is a collaborative pan-European public-private partnership funded through the Innovative Health Initiative (IHI) for five years. PROMINENT will create a digital platform for precision medicine to improve the diagnosis...
In recent years there is mounting evidence that type 2 diabetes (T2D) is associated with cognitive impairment and dementia, which can be considered as a “new” long-term diabetic co-morbid complication...